Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,016 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Value of a Novel Index Combining the Prognostic Nutritional Index and D-Dimer Levels for Gastric Cancer after Gastrectomy.
Yamamoto M, Omori T, Shinno N, Hara H, Mukai Y, Sugase T, Takeoka T, Kanemura T, Mikamori M, Hasegawa S, Akita H, Haraguchi N, Nishimura J, Wada H, Matsuda C, Yasui M, Miyata H, Ohue M. Yamamoto M, et al. Among authors: nishimura j. Oncology. 2023 Dec 30:1-10. doi: 10.1159/000533150. Online ahead of print. Oncology. 2023. PMID: 38160660
Clinicopathological Characteristics and Survival Outcomes in Patients with Advanced Esophageal Squamous Cell Carcinoma Who Were Intraoperatively Diagnosed Non-Curative.
Sugase T, Kanemura T, Takeoka T, Sugimura K, Yamamoto M, Shinno N, Hara H, Omori T, Mukai Y, Mikamori M, Hasegawa S, Haraguchi N, Akita H, Nishimura J, Wada H, Matsuda C, Yasui M, Miyata H. Sugase T, et al. Among authors: nishimura j. Oncology. 2024;102(5):339-349. doi: 10.1159/000533772. Epub 2023 Nov 3. Oncology. 2024. PMID: 37926097
Clinical Impact of Early Tumour Shrinkage in Metastatic or Unresectable Oesophageal Cancer Treated with Pembrolizumab plus Chemotherapy.
Sugase T, Kanemura T, Takeoka T, Matsuura N, Masuike Y, Shinno N, Hara H, Omori T, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Miyata H. Sugase T, et al. Among authors: nishimura j. Oncology. 2024;102(6):484-493. doi: 10.1159/000535186. Epub 2023 Dec 5. Oncology. 2024. PMID: 38052183 Free PMC article.
Prognostic impact of lateral sentinel lymph node biopsy using indocyanine green on oncological outcomes for clinical stage II/III lower rectal cancer without suspected lateral lymph node metastasis.
Sueda T, Yasui M, Nishimura J, Kagawa Y, Kitakaze M, Mori R, Noura S, Omori T, Miyata H, Ohue M. Sueda T, et al. Among authors: nishimura j. Langenbecks Arch Surg. 2024 Oct 18;409(1):311. doi: 10.1007/s00423-024-03501-x. Langenbecks Arch Surg. 2024. PMID: 39422803
Long-Term Efficacy and Safety of Danicopan as Add-On Therapy to Ravulizumab or Eculizumab in PNH With Significant EVH.
Kulasekararaj AG, Griffin M, Piatek CI, Shammo J, Nishimura JI, Patriquin CJ, Schrezenmeier H, Barcellini W, Panse JP, Gaya A, Patel Y, Liu P, Filippov G, Sicre de Fontbrune F, Risitano AM, Lee JW. Kulasekararaj AG, et al. Among authors: nishimura ji. Blood. 2024 Dec 19:blood.2024026299. doi: 10.1182/blood.2024026299. Online ahead of print. Blood. 2024. PMID: 39700502
Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.
Murakami M, Miyata Y, Nakashima K, Abe M, Nishimura J, Wada M, Iino K, Akechi T, Iihara H, Imamura CK, Okuyama A, Ozawa K, Kim YI, Sasaki H, Satomi E, Takeda M, Tanaka R, Nakamura N, Noda M, Hayashi K, Higashi T, Boku N, Matsumoto K, Matsumoto Y, Okita K, Yamamoto N, Aogi K, Nakajima TE. Murakami M, et al. Among authors: nishimura j. Int J Clin Oncol. 2025 Jan;30(1):27-39. doi: 10.1007/s10147-024-02663-4. Epub 2024 Nov 21. Int J Clin Oncol. 2025. PMID: 39570460
Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.
Nakashima K, Harashima S, Kaneko R, Tanaka R, Abe M, Wada M, Iino K, Akechi T, Iihara H, Imamura CK, Okuyama A, Ozawa K, Kim YI, Satomi E, Takeda M, Nakajima TE, Nakamura N, Nishimura J, Noda M, Hayashi K, Higashi T, Boku N, Matsumoto K, Matsumoto Y, Okita K, Yamamoto N, Aogi K, Sasaki H. Nakashima K, et al. Among authors: nishimura j. Int J Clin Oncol. 2025 Jan;30(1):17-26. doi: 10.1007/s10147-024-02652-7. Epub 2024 Nov 12. Int J Clin Oncol. 2025. PMID: 39531096
Influence of the rotation of the diverting loop ileostomy in rectal cancer surgery on small-bowel obstruction: A multicenter prospective study conducted by the Clinical Study Group of Osaka University, Colorectal Group.
Miyo M, Uemura M, Ozato Y, Nishimura J, Nakata K, Suzuki Y, Kagawa Y, Hata T, Munakata K, Tei M, Sawada G, Yoshioka S, Takahashi Y, Oba K, Hata T, Ogino T, Miyoshi N, Yamamoto H, Murata K, Doki Y, Eguchi H; Clinical Study Group of Osaka University, Colorectal Group (CSGO-CG). Miyo M, et al. Among authors: nishimura j. Surgery. 2024 Nov 7:S0039-6060(24)00802-X. doi: 10.1016/j.surg.2024.09.032. Online ahead of print. Surgery. 2024. PMID: 39516112
1,016 results